APO Research
Talk to an analyst

APO RESEARCH · REPORT

Perfluorodecalin for Ophthalmic Surgery

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Perfluorodecalin for Ophthalmic Surgery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025189 pages

Choose your research edition.

Industry ResearchPerfluorodecalin for Ophthalmic Surgery Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Perfluorodecalin for Ophthalmic Surgery Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Perfluorodecalin for Ophthalmic Surgery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Perfluorodecalin for Ophthalmic Surgery Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Perfluorodecalin for Ophthalmic Surgery Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Perfluorodecalin for Ophthalmic Surgery market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Perfluorodecalin for Ophthalmic Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Perfluorodecalin for Ophthalmic Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Perfluorodecalin for Ophthalmic Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Perfluorodecalin for Ophthalmic Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Perfluorodecalin for Ophthalmic Surgery include Alchimia srl, BVI Medical, Geuder AG, Micromed srl, Pharmpur, Toomac Ophthalmic and Bausch + Lomb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Perfluorodecalin for Ophthalmic Surgery market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Perfluorodecalin for Ophthalmic Surgery and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Perfluorodecalin for Ophthalmic Surgery sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Perfluorodecalin for Ophthalmic Surgery market size, projected growth trends, production technologies, key applications, and end-use industries.

Perfluorodecalin for Ophthalmic Surgery Segment by Company

Alchimia srl

BVI Medical

Geuder AG

Micromed srl

Pharmpur

Toomac Ophthalmic

Bausch + Lomb

Perfluorodecalin for Ophthalmic Surgery Segment by Type

Purity ≥ 95%

Purity ≥ 97%

Perfluorodecalin for Ophthalmic Surgery Segment by Application

Hospital

Clinic

Others

Perfluorodecalin for Ophthalmic Surgery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perfluorodecalin for Ophthalmic Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Perfluorodecalin for Ophthalmic Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perfluorodecalin for Ophthalmic Surgery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Perfluorodecalin for Ophthalmic Surgery market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Perfluorodecalin for Ophthalmic Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Perfluorodecalin for Ophthalmic Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Perfluorodecalin for Ophthalmic Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Perfluorodecalin for Ophthalmic Surgery Industry Trends Table 2. Perfluorodecalin for Ophthalmic Surgery Industry Drivers Table 3. Perfluorodecalin for Ophthalmic Surgery Industry Opportunities and Challenges Table 4. Perfluorodecalin for Ophthalmic Surgery Industry Restraints Table 5. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Perfluorodecalin for Ophthalmic Surgery Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Manufacturers Table 9. Global Perfluorodecalin for Ophthalmic Surgery Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Perfluorodecalin for Ophthalmic Surgery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Perfluorodecalin for Ophthalmic Surgery Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Perfluorodecalin for Ophthalmic Surgery Manufacturers, Product Type & Application Table 13. Global Perfluorodecalin for Ophthalmic Surgery Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Perfluorodecalin for Ophthalmic Surgery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity ≥ 95% Table 17. Major Manufacturers of Purity ≥ 97% Table 18. Global Perfluorodecalin for Ophthalmic Surgery Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Perfluorodecalin for Ophthalmic Surgery Sales by Type (2021-2026) & (K Units) Table 20. Global Perfluorodecalin for Ophthalmic Surgery Sales by Type (2027-2032) & (K Units) Table 21. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Type (2021-2026) Table 22. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Type (2027-2032) Table 23. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type (2021-2026) & (K Units) Table 25. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type (2027-2032) & (K Units) Table 26. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Type (2021-2026) Table 27. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Perfluorodecalin for Ophthalmic Surgery Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Perfluorodecalin for Ophthalmic Surgery Sales by Application (2021-2026) & (K Units) Table 33. Global Perfluorodecalin for Ophthalmic Surgery Sales by Application (2027-2032) & (K Units) Table 34. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Application (2021-2026) Table 35. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Application (2027-2032) Table 36. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application (2021-2026) & (K Units) Table 38. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application (2027-2032) & (K Units) Table 39. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Application (2021-2026) Table 40. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Application (2027-2032) Table 41. Global Perfluorodecalin for Ophthalmic Surgery Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Perfluorodecalin for Ophthalmic Surgery Sales by Region (2021-2026) & (K Units) Table 43. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Region (2021-2026) Table 44. Global Perfluorodecalin for Ophthalmic Surgery Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Perfluorodecalin for Ophthalmic Surgery Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Perfluorodecalin for Ophthalmic Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2026) & (K Units) Table 48. North America Perfluorodecalin for Ophthalmic Surgery Sales by Country (2027-2032) & (K Units) Table 49. Europe Perfluorodecalin for Ophthalmic Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2026) & (K Units) Table 51. Europe Perfluorodecalin for Ophthalmic Surgery Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Perfluorodecalin for Ophthalmic Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Perfluorodecalin for Ophthalmic Surgery Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales by Country (2027-2032) & (K Units) Table 58. Global Perfluorodecalin for Ophthalmic Surgery Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Region (2021-2026) Table 62. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Region (2027-2032) Table 63. Alchimia srl Company Information Table 64. Alchimia srl Business Overview Table 65. Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alchimia srl Perfluorodecalin for Ophthalmic Surgery Product Portfolio Table 67. Alchimia srl Recent Development Table 68. BVI Medical Company Information Table 69. BVI Medical Business Overview Table 70. BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BVI Medical Perfluorodecalin for Ophthalmic Surgery Product Portfolio Table 72. BVI Medical Recent Development Table 73. Geuder AG Company Information Table 74. Geuder AG Business Overview Table 75. Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Geuder AG Perfluorodecalin for Ophthalmic Surgery Product Portfolio Table 77. Geuder AG Recent Development Table 78. Micromed srl Company Information Table 79. Micromed srl Business Overview Table 80. Micromed srl Perfluorodecalin for Ophthalmic Surgery Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Micromed srl Perfluorodecalin for Ophthalmic Surgery Product Portfolio Table 82. Micromed srl Recent Development Table 83. Pharmpur Company Information Table 84. Pharmpur Business Overview Table 85. Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pharmpur Perfluorodecalin for Ophthalmic Surgery Product Portfolio Table 87. Pharmpur Recent Development Table 88. Toomac Ophthalmic Company Information Table 89. Toomac Ophthalmic Business Overview Table 90. Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Product Portfolio Table 92. Toomac Ophthalmic Recent Development Table 93. Bausch + Lomb Company Information Table 94. Bausch + Lomb Business Overview Table 95. Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Product Portfolio Table 97. Bausch + Lomb Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Perfluorodecalin for Ophthalmic Surgery Distributors List Table 101. Perfluorodecalin for Ophthalmic Surgery Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Perfluorodecalin for Ophthalmic Surgery Product Image Figure 2. Global Perfluorodecalin for Ophthalmic Surgery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Perfluorodecalin for Ophthalmic Surgery Market Size (2021-2032) & (US$ Million) Figure 4. Global Perfluorodecalin for Ophthalmic Surgery Sales (2021-2032) & (K Units) Figure 5. Global Perfluorodecalin for Ophthalmic Surgery Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Perfluorodecalin for Ophthalmic Surgery Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity ≥ 95% Image Figure 9. Purity ≥ 97% Image Figure 10. Global Perfluorodecalin for Ophthalmic Surgery Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Type (2021-2032) Figure 13. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Perfluorodecalin for Ophthalmic Surgery Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Application (2021-2032) Figure 22. Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Application (2021-2032) Figure 25. North America Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Country (2021-2032) Figure 27. U.S. Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Country (2021-2032) Figure 32. Germany Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Country (2021-2032) Figure 39. China Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Country (2021-2032) Figure 47. Brazil Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Perfluorodecalin for Ophthalmic Surgery Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Perfluorodecalin for Ophthalmic Surgery Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Perfluorodecalin for Ophthalmic Surgery Revenue (2021-2032) & (US$ Million) Figure 58. North America Perfluorodecalin for Ophthalmic Surgery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Perfluorodecalin for Ophthalmic Surgery Revenue (2021-2032) & (US$ Million) Figure 60. Europe Perfluorodecalin for Ophthalmic Surgery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Perfluorodecalin for Ophthalmic Surgery Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Perfluorodecalin for Ophthalmic Surgery Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 95%
  • Purity ≥ 97%
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Alchimia srl
  • BVI Medical
  • Geuder AG
  • Micromed srl
  • Pharmpur
  • Toomac Ophthalmic
  • Bausch + Lomb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Perfluorodecalin for Ophthalmic Surgery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Perfluorodecalin for Ophthalmic Surgery Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Perfluorodecalin for Ophthalmic Surgery Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Perfluorodecalin for Ophthalmic Surgery Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Perfluorodecalin for Ophthalmic Surgery Market Dynamics
  1. 2.1 Perfluorodecalin for Ophthalmic Surgery Industry Trends
  2. 2.2 Perfluorodecalin for Ophthalmic Surgery Industry Drivers
  3. 2.3 Perfluorodecalin for Ophthalmic Surgery Industry Opportunities and Challenges
  4. 2.4 Perfluorodecalin for Ophthalmic Surgery Industry Restraints
3 Perfluorodecalin for Ophthalmic Surgery Market by Manufacturers
  1. 3.1 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Perfluorodecalin for Ophthalmic Surgery Sales by Manufacturers (2021-2026)
  3. 3.3 Global Perfluorodecalin for Ophthalmic Surgery Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Perfluorodecalin for Ophthalmic Surgery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Perfluorodecalin for Ophthalmic Surgery Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Perfluorodecalin for Ophthalmic Surgery Manufacturers, Product Type & Application
  7. 3.7 Global Perfluorodecalin for Ophthalmic Surgery Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Perfluorodecalin for Ophthalmic Surgery Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Perfluorodecalin for Ophthalmic Surgery Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Perfluorodecalin for Ophthalmic Surgery Tier 1, Tier 2, and Tier 3
4 Perfluorodecalin for Ophthalmic Surgery Market by Type
  1. 4.1 Perfluorodecalin for Ophthalmic Surgery Type Introduction
  2. 4.1.1 Purity ≥ 95%
  3. 4.1.2 Purity ≥ 97%
  4. 4.2 Global Perfluorodecalin for Ophthalmic Surgery Sales by Type
  5. 4.2.1 Global Perfluorodecalin for Ophthalmic Surgery Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Perfluorodecalin for Ophthalmic Surgery Sales by Type (2021-2032)
  7. 4.2.3 Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Type (2021-2032)
  8. 4.3 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type
  9. 4.3.1 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Type (2021-2032)
  11. 4.3.3 Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Type (2021-2032)
5 Perfluorodecalin for Ophthalmic Surgery Market by Application
  1. 5.1 Perfluorodecalin for Ophthalmic Surgery Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Perfluorodecalin for Ophthalmic Surgery Sales by Application
  6. 5.2.1 Global Perfluorodecalin for Ophthalmic Surgery Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Perfluorodecalin for Ophthalmic Surgery Sales by Application (2021-2032)
  8. 5.2.3 Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Application (2021-2032)
  9. 5.3 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application
  10. 5.3.1 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Application (2021-2032)
  12. 5.3.3 Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Application (2021-2032)
6 Global Perfluorodecalin for Ophthalmic Surgery Sales by Region
  1. 6.1 Global Perfluorodecalin for Ophthalmic Surgery Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Perfluorodecalin for Ophthalmic Surgery Sales by Region (2021-2032)
  3. 6.2.1 Global Perfluorodecalin for Ophthalmic Surgery Sales by Region (2021-2026)
  4. 6.2.2 Global Perfluorodecalin for Ophthalmic Surgery Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Perfluorodecalin for Ophthalmic Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Perfluorodecalin for Ophthalmic Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Perfluorodecalin for Ophthalmic Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region
  1. 7.1 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region
  2. 7.1.1 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region (2021-2026)
  4. 7.1.3 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Region (2027-2032)
  5. 7.1.4 Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Perfluorodecalin for Ophthalmic Surgery Revenue (2021-2032)
  8. 7.2.2 North America Perfluorodecalin for Ophthalmic Surgery Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Perfluorodecalin for Ophthalmic Surgery Revenue (2021-2032)
  11. 7.3.2 Europe Perfluorodecalin for Ophthalmic Surgery Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Perfluorodecalin for Ophthalmic Surgery Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alchimia srl
  2. 8.1.1 Alchimia srl Company Information
  3. 8.1.2 Alchimia srl Business Overview
  4. 8.1.3 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Product Portfolio
  6. 8.1.5 Alchimia srl Recent Developments
  7. 8.2 BVI Medical
  8. 8.2.1 BVI Medical Company Information
  9. 8.2.2 BVI Medical Business Overview
  10. 8.2.3 BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BVI Medical Perfluorodecalin for Ophthalmic Surgery Product Portfolio
  12. 8.2.5 BVI Medical Recent Developments
  13. 8.3 Geuder AG
  14. 8.3.1 Geuder AG Company Information
  15. 8.3.2 Geuder AG Business Overview
  16. 8.3.3 Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Geuder AG Perfluorodecalin for Ophthalmic Surgery Product Portfolio
  18. 8.3.5 Geuder AG Recent Developments
  19. 8.4 Micromed srl
  20. 8.4.1 Micromed srl Company Information
  21. 8.4.2 Micromed srl Business Overview
  22. 8.4.3 Micromed srl Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Micromed srl Perfluorodecalin for Ophthalmic Surgery Product Portfolio
  24. 8.4.5 Micromed srl Recent Developments
  25. 8.5 Pharmpur
  26. 8.5.1 Pharmpur Company Information
  27. 8.5.2 Pharmpur Business Overview
  28. 8.5.3 Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pharmpur Perfluorodecalin for Ophthalmic Surgery Product Portfolio
  30. 8.5.5 Pharmpur Recent Developments
  31. 8.6 Toomac Ophthalmic
  32. 8.6.1 Toomac Ophthalmic Company Information
  33. 8.6.2 Toomac Ophthalmic Business Overview
  34. 8.6.3 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Product Portfolio
  36. 8.6.5 Toomac Ophthalmic Recent Developments
  37. 8.7 Bausch + Lomb
  38. 8.7.1 Bausch + Lomb Company Information
  39. 8.7.2 Bausch + Lomb Business Overview
  40. 8.7.3 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Product Portfolio
  42. 8.7.5 Bausch + Lomb Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Perfluorodecalin for Ophthalmic Surgery Value Chain Analysis
  2. 9.1.1 Perfluorodecalin for Ophthalmic Surgery Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Perfluorodecalin for Ophthalmic Surgery Production Mode & Process
  6. 9.2 Perfluorodecalin for Ophthalmic Surgery Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Perfluorodecalin for Ophthalmic Surgery Distributors
  9. 9.2.3 Perfluorodecalin for Ophthalmic Surgery Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst